argenx SE (ARGX)
605.92
+9.18
(+1.54%)
USD |
NASDAQ |
Nov 22, 16:00
597.01
-8.91
(-1.47%)
After-Hours: 20:00
argenx Shareholders Equity (Quarterly)
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 4.262B |
| December 31, 2023 | 4.098B |
| June 30, 2023 | 2.858B |
| December 31, 2022 | 2.814B |
| June 30, 2022 | 2.970B |
| December 31, 2021 | 2.534B |
| June 30, 2021 | 2.952B |
| December 31, 2020 | 1.674B |
| June 30, 2020 | 1.818B |
| December 31, 2019 | 1.180B |
| June 30, 2019 | 756.55M |
| June 30, 2019 | 756.55M |
| December 31, 2018 | 615.87M |
| Date | Value |
|---|---|
| June 30, 2018 | 384.97M |
| June 30, 2018 | 384.97M |
| December 31, 2017 | 413.81M |
| June 30, 2017 | 171.88M |
| December 31, 2016 | 66.65M |
| June 30, 2016 | 83.87M |
| December 31, 2015 | 40.76M |
| June 30, 2015 | 49.56M |
| December 31, 2014 | 60.90M |
| June 30, 2014 | 23.88M |
| March 31, 2014 | 27.33M |
| December 31, 2013 | 29.97M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
1.180B
Minimum
Dec 2019
4.262B
Maximum
Jun 2024
2.716B
Average
2.836B
Median
Shareholders Equity (Quarterly) Benchmarks
| Biodexa Pharmaceuticals PLC | 11.04M |
| uniQure NV | 55.82M |
| ProQR Therapeutics NV | 27.90M |
| Akari Therapeutics PLC | -6.694M |
| Merus NV | 703.26M |